Topics
Gliomas | Treatment | Targeted therapy | Ivosidenib
Home > Publications > Topics > Gliomas > Treatment > Targeted therapy > Ivosidenib
Still MEH, Moor RSF, Ghiaseddin AP, Leibetseder A, Hottinger AF,
Berghoff A, Leung D.
How do I
prescribe and manage mIDH inhibitors in patients with IDH-mutant
glioma?
Neurooncol
Pract. 2024 Dec 3;12(Suppl 1):i19-i25. doi:
10.1093/nop/npae112. PMID:
39776526. Review. ˍ
Roth P, Capper D, Calabrese E, Halasz LM, Jakola AS.
Role
of the tumor board when
prescribing mutant isocitrate dehydrogenase inhibitors to patients
with isocitrate
dehydrogenase-mutant glioma.
Neurooncol
Pract. 2024 Dec 4;12(Suppl 1):i29-i37. doi:
10.1093/nop/npae100. PMID:
39776528. Review. ˍ